Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments
A qualitative study in Ethiopia reveals that health workers and patients view shorter-course malaria treatments as promising but harbour significant…
Editor's Top Picks
Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial
A multicenter randomized trial in The Lancet Regional Health – Western Pacific found that sitafloxacin monotherapy is non-inferior to standard…
Submit Your Paper to GMJ
Heart Shows Aging Signs by Age 40, While Brain Remains Resilient Until 60s, Cell Study Reveals
New Cell study reveals heart and kidneys show aging by age 40, while brain remains resilient until 60s. Age 55…
Spinal Nerve Network Controls Body Functions Beyond Back Pain, Research Shows
New research reveals the spine functions as the body's central wiring harness, with each vertebral level controlling specific organs and…
Gut’s 7-Meter Assembly Line Maps Nutrient Absorption with Molecular Precision
The human gastrointestinal tract functions as a 7-meter specialized assembly line, with each segment precisely engineered to absorb specific nutrients.…
Why Creatine Works Differently in Muscle and Brain: New Research Reveals Transport Barriers
Three decades of research reveals creatine supplements increase muscle creatine by up to 40% but brain levels by only 3.7%,…
Multivitamin supplements show clear benefits for cognitive function and pregnancy outcomes
New research analyzing dozens of studies reveals significant cognitive and pregnancy benefits from daily multivitamin supplementation. The comprehensive review challenges…
New Three-Day Creatine Loading Protocol Shows Promise in Small Trial
New three-day creatine loading protocol using pre-exercise timing shows performance improvements in small crossover trial. Strategic timing of initial dose…
WHO Raises Ebola Risk to ‘Very High’ in Democratic Republic of Congo
WHO escalates Ebola outbreak risk to 'very high' within Democratic Republic of Congo while maintaining regional risk at 'high' and…
UK Scientists Rush to Develop Vaccine for Deadly Bundibugyo Ebola Strain
UK scientists are developing a vaccine for the deadly Bundibugyo Ebola strain that kills 33% of infected patients. Clinical trials…